The study, published in the September issue of Environmental Toxicology and Pharmacology, found that when lab rats were given small doses of the CBD cannabinoid, in conjunction with a standard doses of Doxil, there was no detectable heart issues associated with the doxorubicin. And the rats that were exposed to doxorubicin, but not given any CBD, showed signs of notable harm done by the drug
Doxil is part of a family of chemotherapy drugs, and is designed to slow or stop the growth of cancer cells. But its use may lead to “cardiac toxicity” (read: heart problems).
The study was conducted by researchers at the College of Medicine, King Faisal University at Al-Ahsa, Saudi Arabia.
Photo courtesy Flickr user Sam Blackman